|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Amortization of discount/premium, deferred fees and payment-in-kind interest | |||||
| Amortization of deferred financing costs | |||||
| Straight-line rent amortization | |||||
| Equity-based compensation | |||||
| Increase in current expected credit loss allowance, net | |||||
| Foreign currency loss (gain) | |||||
| Unrealized loss on derivatives | |||||
| Foreign Exchange Forward | |||||
| Interest rate caps and swaps | |||||
| Depreciation and amortization on real estate owned | |||||
| Loss from unconsolidated joint venture | |||||
| Income from equity method investment | |||||
| Gain on extinguishment of debt | |||||
| Net realized loss on investment | |||||
| Changes in operating assets and liabilities: | |||||
| Proceeds received from payment-in-kind interest | |||||
| Other assets | |||||
| Payment for interest rate cap | |||||
| Origination of subordinate loan, held for sale | |||||
| Sale of subordinate loan, held for sale | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Payable to related party | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| New funding of commercial mortgage loans | |||||
| Add-on funding of commercial mortgage loans | |||||
| Add-on funding of subordinate loans | |||||
| Proceeds received from the repayment and sale of commercial mortgage loans | |||||
| Proceeds received from the repayment of subordinate loans and other lending assets | |||||
| Proceeds and payments received of notes receivable, held for sale | |||||
| Contributions to equity method investment | |||||
| Distributions from equity method investment | |||||
| Origination fees, other fees, and cost recovery proceeds received on commercial mortgage loans, and subordinate loans, net | |||||
| Increase (decrease) in collateral related to derivative contracts, net | |||||
| Capital expenditures on real estate owned assets | |||||
| Proceeds received from the sale of other assets | |||||
| Cash received from hotel title assumption | |||||
| Proceeds received from the sale of real estate owned, held for sale | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Payment of offering costs | |||||
| Proceeds from secured debt arrangements | |||||
| Proceeds related to financing on real estate owned | |||||
| Repayment of debt related to real estate owned | |||||
| Repayments of secured debt arrangements | |||||
| Repayments of senior secured term loan principal | |||||
| Repayments and repurchases of convertible notes | |||||
| Proceeds from issuance of senior secured term loan | |||||
| Proceeds from issuance of senior secured notes | |||||
| Payment of deferred financing costs | |||||
| Payment of issuance discount | |||||
| Payment of withholding tax on RSU delivery | |||||
| Repurchase of common stock | |||||
| Dividends on common stock | |||||
| Dividends on preferred stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents, including cash classified within assets related to real estate owned, held for sale | |||||
| Decrease in cash classified within assets related to real estate owned, held for sale | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents beginning of period | |||||
| Effects of foreign currency translation on cash and cash equivalents | |||||
| Cash and cash equivalents end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Income tax paid | |||||
| Change in loan proceeds held by servicer | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Dividend declared, not yet paid | |||||
| Change in participation sold | |||||
| Repayments of payment-in-kind on participation sold | |||||
| Assumption of debt related to real estate owned | |||||
| Assumption of other assets related to real estate owned | |||||
| Assumption of accounts payable, accrued expenses and other liabilities related to real estate owned | |||||
| Transfer of assets to assets related to real estate owned, held for sale | |||||
| Transfer of assets related to real estate owned, held for sale to assets related to real estate owned held for investment, net | |||||
| Transfer of assets related to real estate owned, held for sale to other assets | |||||
| Transfer of liabilities to liabilities related to real estate owned, held for sale | |||||
| Transfer of liabilities related to real estate owned, held for sale to accounts payable, accrued expenses and other liabilities | |||||
| Transfer of subordinate loan to subordinate loan, held for sale | |||||
| Retirement of Series B Preferred Stock | |||||
| Issuance of Series B-1 Preferred Stock | |||||
| Transfer of commercial mortgage loan to other assets | |||||
| Note receivable, held for sale | |||||
| Restructuring of commercial mortgage loan to subordinate loan | |||||
| Loan modification accounted for as a new loan | |||||
| Restructuring of subordinate loan to commercial mortgage loan | |||||
Loading...
